triazolam has been researched along with Agitation, Psychomotor in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Excerpt | Relevance | Reference |
---|---|---|
"Side effects involving agitation, e." | 1.27 | Agitation observed during treatment with newer hypnotic drugs. ( Regestein, QR; Reich, P, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cotroneo, A | 1 |
Gareri, P | 1 |
Nicoletti, N | 1 |
Lacava, R | 1 |
Grassone, D | 1 |
Maina, E | 1 |
De Sarro, G | 1 |
Cabodi, S | 1 |
Regestein, QR | 1 |
Reich, P | 1 |
2 other studies available for triazolam and Agitation, Psychomotor
Article | Year |
---|---|
Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
Topics: Aged; Cognition Disorders; Dementia; Depression; Drug Administration Schedule; Female; Health Status | 2007 |
Agitation observed during treatment with newer hypnotic drugs.
Topics: Adult; Aged; Akathisia, Drug-Induced; Anger; Anti-Anxiety Agents; Female; Half-Life; Hostility; Huma | 1985 |